THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 110 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $487,000 | +1523.3% | 48,092 | +1308.3% | 0.00% | – |
Q2 2022 | $30,000 | -62.5% | 3,415 | -59.4% | 0.00% | – |
Q1 2022 | $80,000 | -68.5% | 8,401 | -63.6% | 0.00% | – |
Q4 2021 | $254,000 | +2016.7% | 23,065 | +2613.5% | 0.00% | – |
Q3 2021 | $12,000 | +20.0% | 850 | +13.3% | 0.00% | – |
Q2 2021 | $10,000 | – | 750 | +4900.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 15 | -98.6% | 0.00% | – |
Q2 2020 | $23,000 | -86.7% | 1,103 | -83.5% | 0.00% | – |
Q4 2019 | $173,000 | +76.5% | 6,689 | +32.6% | 0.00% | – |
Q3 2019 | $98,000 | +55.6% | 5,043 | +30.3% | 0.00% | – |
Q2 2019 | $63,000 | – | 3,871 | +64416.7% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 6 | -96.2% | 0.00% | – |
Q4 2018 | $4,000 | +300.0% | 157 | +324.3% | 0.00% | – |
Q3 2018 | $1,000 | -93.8% | 37 | -94.8% | 0.00% | – |
Q2 2018 | $16,000 | – | 709 | +2115.6% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 32 | -97.3% | 0.00% | -100.0% |
Q3 2017 | $40,000 | -71.4% | 1,177 | -66.7% | 0.00% | -66.7% |
Q2 2017 | $140,000 | +382.8% | 3,538 | +329.4% | 0.01% | +200.0% |
Q3 2016 | $29,000 | +262.5% | 824 | +129.5% | 0.00% | +100.0% |
Q2 2016 | $8,000 | – | 359 | +11866.7% | 0.00% | – |
Q1 2016 | $0 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |